# Odyssey funding rounds and investors

As of 14 Oct 2026, Odyssey has raised $213M across 1 verified round on record; latest: $213 million Series D, announced 10 Sep 2025.

Odyssey Therapeutics develops innovative therapies aimed at transforming the treatment of autoimmune and inflammatory diseases for patients.

Website: https://odysseytx.com  
Headquarters: Boston  
Page: https://fireround.dev/companies/odysseytx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-09-10 | Series D | $213 million | not stated | Affinity Asset Advisors, Dimension, Jeito Capital, Lightspeed, TPG Life Sciences Innovations, Wedbush Healthcare Partners | [fiercebiotech.com](https://www.fiercebiotech.com/biotech/odyssey-therapeutics-heralds-213m-series-d-strengthen-clinical-portfolio) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.